Back to companies

Edwards Lifesciences Corp: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that is engaged in the development, manufacturing and marketing of devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, transcatheter heart valves, hemodynamic monitoring devices, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.

Headquarters United States of America

Address 1 Edwards Way, One Edwards Way, Irvine, California, 92614


Telephone 1 949 2502500

No of Employees 15,700

Industry Medical Equipment

Ticker Symbol & Exchange EW (NYSE)

Revenue (2021) $5.2B 19.3% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 82.5% (2021 vs 2020)

Market Cap* $56.4B

Net Profit Margin (2021) XXX 53.1% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

320+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

140+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

50+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

8

Clinical Trials

Determine Edwards Lifesciences Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1

Investigators

Review investigator profiles and find information on trial contacts across Edwards Lifesciences Corp, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Surgical Valve Repair: AnastaFlo
Mitral Valve Repair AVA 3Xi/HF
Tricuspid Valve Repair Carpentier
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 New Product Approvals In March, the company's Mitris Resilia valve received the US FDA approval for mitral replacement surgeries
2021 Contracts/Agreements In April, the company entered into a partnership with Providence, Cities of Irvine, Santa Ana, Costa Mesa and Tustin to open two free mass COVID-19 vaccination clinics.
2019 Regulatory Approval In December, Edwards Lifesciences obtained FDA approval for its Sapien 3 transcatheter heart valve for the treatment of patients with severe, symptomatic aortic stenosis who possess low risk of open-heart surgery.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Edwards Lifesciences Corp Abbott Laboratories Medtronic Plc Boston Scientific Corp LivaNova Plc
Headquarters United States of America United States of America Ireland United States of America United Kingdom
City Irvine Abbott Park Dublin Natick London
State/Province California Illinois - Massachusetts -
No. of Employees 15,700 113,000 90,000 41,000 3,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Michael A. Mussallem Chairman; Chief Executive Officer Executive Board 2000 69
Scott B. Ullem Chief Financial Officer; Corporate Vice President Senior Management 2014 55
Todd J. Brinton, M.D. Chief Scientific Officer; Corporate Vice President - Advanced Technology Senior Management 2019 -
Joseph Nuzzolese Corporate Vice President - Global Supply Chain Senior Management 2016 -
Arnold A. Pinkston Corporate Vice President; General Counsel Senior Management 2019 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer